With over four years dedicated to pharmaceutical Market Access at AstraZeneca, I am deeply immersed in developing access strategies that resonate with our mission of delivering value through innovative healthcare solutions. Our team is committed to optimizing patient affordability and driving access to life-saving medications. In my role, I've honed skills such as competitive insight and learning agility, ensuring that AstraZeneca remains at the forefront of patient access in a rapidly evolving healthcare landscape.In my current tenure as Director of Access Strategy, we've led groundbreaking negotiations for the Inflation Reduction Act Drug with the Centers for Medicare and Medicaid Services. My focus has been on developing national payer account negotiation strategies and enhancing patient affordability. These efforts have underscored my commitment to ensuring that patients can access the treatments they need, a testament to the collaborative spirit and strategic foresight that define our team's approach to access strategy.